SGH
Sivik Global Healthcare Portfolio holdings
AUM
$224M
This Quarter Return
-0.67%
1 Year Return
+5.3%
3 Year Return
+45.33%
5 Year Return
+103.79%
10 Year Return
+430.94%
AUM
$198M
AUM Growth
+$198M
(-21%)
Cap. Flow
-$49.5M
Cap. Flow
% of AUM
-24.96%
Top 10 Holdings %
Top 10 Hldgs %
35.51%
Holding
63
New
3
Increased
15
Reduced
20
Closed
18
Top Buys
| 1 |
Alcon
ALC
|
$5.83M |
| 2 |
Grifois
GRFS
|
$3.91M |
| 3 |
Zoetis
ZTS
|
$3.74M |
| 4 |
Cigna
CI
|
$3.04M |
| 5 |
HCA Healthcare
HCA
|
$2.41M |
Top Sells
| 1 |
Pfizer
PFE
|
$6.5M |
| 2 |
Molina Healthcare
MOH
|
$5.73M |
| 3 |
Elanco Animal Health
ELAN
|
$5.07M |
| 4 |
WMGI
Wright Medical Group Inc
WMGI
|
$4.77M |
| 5 |
Smith & Nephew
SNN
|
$4.35M |
Sector Composition
| 1 | Healthcare | 95.79% |
| 2 | Energy | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Boston Scientific
BSX
$156B
| $8.14M | 4.11% |
200,000
| – | – |
|
2
Universal Health Services
UHS
$11.6B
| $7.44M | 3.75% |
50,000
+10,000
| +25% | +$1.49M |
|
3
Humana
HUM
$36.5B
| $7.41M | 3.74% |
29,000
-3,500
| -11% | -$895K |
|
|
4
HCA Healthcare
HCA
$94.5B
| $7.23M | 3.65% |
60,000
+20,000
| +50% | +$2.41M |
|
5
Merck
MRK
$210B
| $7.16M | 3.61% |
85,000
+15,000
| +21% | +$1.26M |
|
6
Vertex Pharmaceuticals
VRTX
$100B
| $6.78M | 3.42% |
40,000
+10,000
| +33% | +$1.69M |
|
7
Abbott
ABT
$231B
| $6.69M | 3.38% |
80,000
| – | – |
|
8
Baxter International
BAX
$12.7B
| $6.56M | 3.31% |
75,000
-10,000
| -12% | -$875K |
|
9
Danaher
DHR
$147B
| $6.5M | 3.28% |
45,000
-5,000
| -10% | -$722K |
|
10
Sanofi
SNY
$121B
| $6.49M | 3.27% |
140,000
+40,000
| +40% | +$1.85M |
|
11
Eli Lilly
LLY
$657B
| $6.15M | 3.1% |
55,000
| – | – |
|
12
Bio-Rad Laboratories Class A
BIO
$8.06B
| $5.99M | 3.02% |
18,000
+500
| +3% | +$166K |
|
|
13
Grifois
GRFS
$6.78B
| $5.91M | 2.98% |
295,000
+194,980
| +195% | +$3.91M |
|
|
14
Alcon
ALC
$39.5B
| $5.83M | 2.94% |
+100,000
| New | +$5.83M |
|
15
Regeneron Pharmaceuticals
REGN
$61.5B
| $5.55M | 2.8% |
20,000
| – | – |
|
16
Edwards Lifesciences
EW
$47.8B
| $5.5M | 2.77% |
25,000
-6,000
| -19% | -$1.32M |
|
17
UnitedHealth
UNH
$281B
| $5.43M | 2.74% |
25,000
-5,000
| -17% | -$1.09M |
|
18
Stryker
SYK
$150B
| $5.41M | 2.73% |
25,000
+10,000
| +67% | +$2.16M |
|
19
Quest Diagnostics
DGX
$20.3B
| $5.35M | 2.7% |
50,000
+20,000
| +67% | +$2.14M |
|
|
WCG
20
DELISTED
Wellcare Health Plans, Inc.
WCG
| $5.18M | 2.62% |
20,000
| – | – |
|
21
Becton Dickinson
BDX
$55.3B
| $5.06M | 2.55% |
20,000
-12,500
| -38% | -$3.16M |
|
22
Labcorp
LH
$23.1B
| $5.04M | 2.54% |
30,000
-5,000
| -14% | -$840K |
|
|
CELG
23
DELISTED
Celgene Corp
CELG
| $4.97M | 2.51% |
50,000
-10,000
| -17% | -$993K |
|
24
IQVIA
IQV
$32.4B
| $4.48M | 2.26% |
30,000
+15,000
| +100% | +$2.24M |
|
25
Thermo Fisher Scientific
TMO
$186B
| $4.37M | 2.2% |
15,000
| – | – |
|